Pulmonary Medicine

Respiratory syncytial virus a vector candidate for treating pulmonary disease

Published in Gene Therapy Weekly, July 18th, 2002

by Sonia Nichols, senior medical writer - A virus known for causing pulmonary illness in infants and young children has demonstrated the potential for being an effective vector candidate in the treatment of lung diseases with gene therapies.

Respiratory syncytial virus (RSV) is most often recognized for causing severe pulmonary illness, including bronchitis and pneumonia, in young children, and mild or no pulmonary symptoms in adults. Medical investigators are now saying that RSV could provide a vehicle for transporting therapeutic genes to cells in the lungs while causing little harm to the treated patient.

Researchers at the University of North...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-07-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry